Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cancer-related depression and potential pharmacologic therapies.

Literature DB >> 18982092

Cancer-related depression and potential pharmacologic therapies.

Aimee Ginsburg¹.

Abstract

Entities: Disease

Year: 2008 PMID： 18982092 PMCID： PMC2566922 DOI： 10.1080/08998280.2008.11928449

Source DB: PubMed Journal: Proc (Bayl Univ Med Cent) ISSN： 0899-8280

× No keyword cloud information.

17 in total

Review 1. Psychopharmacology in supportive care of cancer: a review for the clinician. IV. Other psychotropic agents.

Authors: T Buclin; C Mazzocato; A Berney; F Stiefel
Journal: Support Care Cancer Date: 2001-06 Impact factor: 3.603

2. The effect of fluoxetine on anxiety and depression symptoms in cancer patients.

Authors: D Razavi; J F Allilaire; M Smith; A Salimpour; M Verra; B Desclaux; P Saltel; I Piollet; A Gauvain-Piquard; C Trichard; B Cordier; R Fresco; E Guillibert; D Sechter; J P Orth; M Bouhassira; P Mesters; P Blin
Journal: Acta Psychiatr Scand Date: 1996-09 Impact factor: 6.392

Review 3. Psychostimulants in supportive care.

Authors: J Homsi; D Walsh; K A Nelson
Journal: Support Care Cancer Date: 2000-09 Impact factor: 3.603

4. Dextroamphetamine with morphine for the treatment of postoperative pain.

Authors: W H Forrest; B W Brown; C R Brown; R Defalque; M Gold; H E Gordon; K E James; J Katz; D L Mahler; P Schroff; G Teutsch
Journal: N Engl J Med Date: 1977-03-31 Impact factor: 91.245

Review 5. Treatment of depression in cancer.

Authors: Michael Fisch
Journal: J Natl Cancer Inst Monogr Date: 2004

2. Antidepressants Fluoxetine Mediates Endoplasmic Reticulum Stress and Autophagy of Non-Small Cell Lung Cancer Cells Through the ATF4-AKT-mTOR Signaling Pathway.

Authors: Shali Shao; Xibing Zhuang; Lin Zhang; Tiankui Qiao
Journal: Front Pharmacol Date: 2022-05-10 Impact factor: 5.988

3. A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.

Authors: Ralph J Johnson
Journal: BMC Psychiatry Date: 2018-04-03 Impact factor: 3.630

3 in total

Cancer-related depression and potential pharmacologic therapies.

Review 1. Psychopharmacology in supportive care of cancer: a review for the clinician. IV. Other psychotropic agents.

2. The effect of fluoxetine on anxiety and depression symptoms in cancer patients.

Review 3. Psychostimulants in supportive care.

4. Dextroamphetamine with morphine for the treatment of postoperative pain.

Review 5. Treatment of depression in cancer.

6. A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer.

7. Bupropion sustained release treatment reduces fatigue in cancer patients.

8. Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma.

Review 9. Cancer pain and depression: management of the dual-diagnosed patient.

10. Trimipramine in physical illness with depression.

1. Intervention of mirtazapine on gemcitabine-induced mild cachexia in nude mice with pancreatic carcinoma xenografts.

2. Antidepressants Fluoxetine Mediates Endoplasmic Reticulum Stress and Autophagy of Non-Small Cell Lung Cancer Cells Through the ATF4-AKT-mTOR Signaling Pathway.

3. A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea.